🔎 Trials Near Me

Home › Steatotic Liver Disease › Pennsylvania

Steatotic Liver Disease clinical trials in Pennsylvania

5 studies for Steatotic Liver Disease are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

  • Geisinger Medical Center, Danville
  • Penn State Health Milton S. Hershey Medical Center, Hershey
  • University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • US Digestive Health - Flourtown, Flourtown
  • Penn Medicine: University of Pennsylvania Health System, Philadelphia
  • US Digestive Health - Wyomissing, Wyomissing
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Hershey
  • Akero Clinical Study Site, Philadelphia
  • Akero Clinical Study Site, Philadelphia
  • and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Philadelphia
  • 89bio Clinical Study Site, Pittsburgh
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

  • GSK Investigational Site, Philadelphia
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Aug 3, 2026 · NCT06613698

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.